Seth H. Z. Fischer - 28 Oct 2021 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ESPR	Stock Option (right to buy)						40,000	28 Oct 2021	Common Stock	40,000	$8.85	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The awards vest over a three (3) year period in equal annual installments, the first of which will be October 28, 2022.